FIM
WGS icon

Freedom Investment Management’s GeneDx Holdings WGS Stock Holding History

Freedom Investment Management’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-343
Closed -$2.99K – 802
2022
Q4 		$2.99K Sell
343
-36
-9% -$793 ﹤0.01% 702
2022
Q3 		$11K Buy
+379
New +$17.4K ﹤0.01% 718

Other funds holding WGS

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
CM
Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Freedom Investment Management's WGS Position: Q1 2023 in Review

Freedom Investment Management sold out of GeneDx Holdings (WGS) in Q1 2023, closing a stake of 343 shares — an estimated $2.99K sold.

Freedom Investment Management first reported a position in WGS in Q3 2022 and held it in 2 quarters. The position peaked at $11K in Q3 2022. 82 funds tracked by Wall St. Rank hold WGS as of Q1 2023.

  • Freedom Investment Management reported no remaining GeneDx Holdings position as of Q1 2023 after selling out during the quarter.
  • Freedom Investment Management sold 343 GeneDx Holdings shares in Q1 2023, an estimated $2.99K.
  • Freedom Investment Management first reported a position in GeneDx Holdings in Q3 2022 and held it in 2 quarters.
  • Freedom Investment Management's GeneDx Holdings position peaked at $11K in Q3 2022.
  • 82 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2023.

Based on Freedom Investment Management's 13F filing for Q1 2023, filed 15 May 2023.